Evidence map›Paper›PMID 34484240›Full record

ArticleFrontiers in immunology2021

Targeting the Microtubule-Network Rescues CTL Killing Efficiency in Dense 3D Matrices.

Renping Zhao, Xiangda Zhou, Essak S Khan, Dalia Alansary, Kim S Friedmann, Wenjuan Yang, Eva C Schwarz, Aránzazu Del Campo, Markus Hoth, Bin Qu

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Immune cells employ intermittent integrin-mediated traction forces for 3D migration.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Imaging actin organisation and dynamics in 3D.Journal of cell science · 2024
    Article
  12. Article
  13. Review
  14. Bioactive Constituents ofInternational journal of molecular sciences · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Renping ZhaoBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Xiangda ZhouBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Essak S KhanINM-Leibniz Institute for New Materials, Saarbrücken, Germany.
Dalia AlansaryMolecular Biophysics, CIPMM, School of Medicine, Saarland University, Homburg, Germany.
Kim S FriedmannBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Wenjuan YangBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Eva C SchwarzBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Aránzazu Del CampoINM-Leibniz Institute for New Materials, Saarbrücken, Germany.
Markus HothBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Bin QuBiophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Saarland University · DELeibniz-Institute for New Materials · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficacy of cytotoxic T lymphocyte (CTL)-based immunotherapy is still unsatisfactory against solid tumors, which are frequently characterized by condensed extracellular matrix. Here, using a unique 3D killing assay, we identify that the killing efficiency of primary human CTLs is substantially impaired in dense collagen matrices. Although the expression of cytotoxic proteins in CTLs remained intact in dense collagen, CTL motility was largely compromised. Using light-sheet microscopy, we found that persistence and velocity of CTL migration was influenced by the stiffness and porosity of the 3D matrix. Notably, 3D CTL velocity was strongly correlated with their nuclear deformability, which was enhanced by disruption of the microtubule network especially in dense matrices. Concomitantly, CTL migration, search efficiency, and killing efficiency in dense collagen were significantly increased in microtubule-perturbed CTLs. In addition, the chemotherapeutically used microtubule inhibitor vinblastine drastically enhanced CTL killing efficiency in dense collagen. Together, our findings suggest targeting the microtubule network as a promising strategy to enhance efficacy of CTL-based immunotherapy against solid tumors, especially stiff solid tumors.

Indexed as

Cytotoxicity, ImmunologicImmunotherapy, AdoptiveCell Line, TumorCell MovementCoculture TechniquesCollagen Type IElasticityExtracellular MatrixHumansHydrogelsMicrotubulesNeoplasmsPorosityT-Lymphocytes, CytotoxicTubulin ModulatorsVinblastineCollagen Type IHydrogelsTubulin ModulatorsVinblastine3D killingcollagenCTLsdense matricesmicrotubulesmigrationnuclear deformation

Identifiers

PMID34484240
PMCPMC8416057
OpenAlexW3195954709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.